Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.310
-0.090 (-3.75%)
At close: Jul 7, 2026, 4:00 PM EDT
2.350
+0.040 (1.73%)
After-hours: Jul 7, 2026, 6:02 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $416.62 million as of July 7, 2026. Its market cap has increased by 730.98% in one year.
Market Cap
416.62M
Enterprise Value
329.84M
1-Year Change
730.98%
Ranking
Category
Stock Price
$2.31
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $416.62M, a decrease of -60.36%. That is a compound annual growth rate of -16.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 416.62M | 379.65% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artiva Biotherapeutics | 466.93M |
| Evommune | 466.80M |
| Benitec Biopharma | 454.16M |
| Enanta Pharmaceuticals | 439.37M |
| vTv Therapeutics | 439.30M |
| Eupraxia Pharmaceuticals | 438.32M |
| Autolus Therapeutics | 420.51M |
| Puma Biotechnology | 420.43M |